In this video, Darren Brenner, MD, gives a preview of his presentation on the management of irritable bowel syndrome in primary care, which will be presented at the Practical Updates in Primary Care 2020...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
In this video, James Matera, MD, talks about the critical questions patients have about CKD, the impact of CKD on comorbid conditions and the need to limit risk, and more.
In this video, James Matera, MD, talks about the critical questions patients have about CKD, the impact of CKD on comorbid conditions and the need to limit risk, and more.
In this video, James Matera, MD, talks about the critical questions patients have about CKD, the impact of CKD on comorbid conditions and the need to limit risk, and more.
James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.
James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.
